EGC is leading a collaborative national effort to raise awareness of a new tax law that requires capitalization of Research & Experimentation (R&E) expenses and detrimentally impacts companies conducting critical scientific work. Our letter to Congress has been signed by 501 companies and individuals from 48 states and DC, and is available here. We encourage scientific companies impacted by this law to reach out to your local representatives, and for SBIR/STTR companies to also reach out to the SBA at technology@sba.gov, to help spread awareness of the impact on your company. Full press release is available here.
Accelerating development of innovative technologies
EGC’s extraordinary team of scientists and accountants are ready to secure and manage non-dilutive funding to support your scientific innovations. Contact us to learn more.
Related Posts
September 4, 2024
September 2024 Newsletter
EGC’s September newsletter celebrates the success of our client Merlin Therapeutics and showcases two upcoming webinars – “Entity Formation Overview”…
August 29, 2024
Fall 2024 Grant Webinar Series | Harvesting America’s Seed Fund: Guidance for Navigating the NSF’s SBIR / STTR Application Process
Eva Garland Consulting (EGC) is pleased to announce a new three-part Fall 2024 Grant Webinar Series. This series is part of EGC’s continued…
August 19, 2024
Join the 3rd Session of the Government Accounting & Legal Compliance Webinar Series: Entity Formation Overview
Choosing the right business entity is absolutely crucial to a growing company as it will ultimately affect its legal protection, tax obligations,…
August 7, 2024
Government Accounting & Legal Compliance Webinar Series: HR Guidance and Best Practices
This session covered legal updates and best practices for independent contractors, employment agreements, and workplace policies.